Overview
France eyewear giant's FY revenue grew 11.2%, beating analyst expectations
Adjusted operating margin at 16% impacted by US tariffs and AI-glasses
AI-glasses sold over 7 mln units in FY, boosting company performance
Outlook
EssilorLuxottica plans solid revenue growth over next five years at constant exchange rates
Company expects adjusted operating profit growth aligned with revenue growth
Result Drivers
AI-GLASSES SALES - Co sold over 7 mln units of AI-glasses in FY, contributing significantly to revenue growth
MYOPIA MANAGEMENT - Myopia management portfolio revenue increased by 22% worldwide, indicating strong demand
REGIONAL GROWTH - North America, EMEA, and Asia-Pacific regions all reported double-digit growth in Q4 and FY
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
FY Revenue
Beat
EUR 28.49 bln
EUR 28.04 bln (20 Analysts)
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 22 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"
Wall Street's median 12-month price target for EssilorLuxottica SA is €333.50, about 33.1% above its February 10 closing price of €250.50
The stock recently traded at 33 times the next 12-month earnings vs. a P/E of 41 three months ago
Press Release: ID:nGNEb5bMZn
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)